Prof. Luís Henrique W. Gowdak A new* solution to revive the metabolic power of the heart in patients with chronic coronary syndrome
About the event
The Clarify registry revealed that 33.9% of patients with angina symptoms when included in the registry, were still experiencing symptoms 5 years after, reflecting the need for innovative and effective anti-anginal therapy. 1
In this video, Prof. Luís Henrique W. Gowdak, cardiologist and investigator from Brazil, introduces us to VASTAREL OD 80mg, a brand new solution for the treatment of symptomatic patients with chronic coronary syndrome.
VASTAREL OD 80mg has a unique metabolic mode of action, allowing to optimize the use of O2 and to increase the production of ATP, while improving contractility at the cardiac level. 2,3
* prolonged-release formulation
1. Mesnier J et al; CLARIFY Investigators. International observational analysis of evolution and outcomes of chronic stable angina: the multinational CLARIFY study. Circulation. 2021;144⁷:512-23 2. Lopaschuk GD & Stanley WC. Glucose metabolism in the ischemic heart. Circulation. 1997;95²:313-5 3. Hu B et all. Evaluation of trimetazidine in angina pectoris by echocardiography and radionuclide angiography: a meta-analysis of randomized, controlled trials. Clin Cardiol. 2011;34⁶:395-400
"
Don't miss our next events!
Subscribe to our newsletter to receive invitations to upcoming events
You can unsubscribe at any time by clicking on the link in our emails.